The investment seeks long-term capital growth... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeGrowth
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GOFIX | 18.62 | 0.40 | +2.20% |
GMO Resources III | |||
CMNWX | 79.29 | -1.01 | -1.26% |
Principal Capital Appreciation A | |||
BSCMX | 17.32 | -0.30 | -1.70% |
Brandes Small Cap Value I | |||
QCSGX | 19.64 | -0.36 | -1.80% |
Federated Hermes MDT Small Cap Growth C | |||
PHPIX | 22.72 | -0.46 | -1.98% |
ProFunds Pharmaceuticals UltraSector Inv |
A.I.dvisor indicates that over the last year, VRLCX has been closely correlated with VIGRX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if VRLCX jumps, then VIGRX could also see price increases.
Ticker / NAME | Correlation To VRLCX | 1D Price Change % | ||
---|---|---|---|---|
VRLCX | 100% | -1.23% | ||
VIGRX - VRLCX | 94% Closely correlated | -1.33% | ||
VIGAX - VRLCX | 94% Closely correlated | -1.33% | ||
VIGIX - VRLCX | 94% Closely correlated | -1.33% | ||
GAFFX - VRLCX | 92% Closely correlated | -1.20% | ||
FAFGX - VRLCX | 92% Closely correlated | -1.19% | ||
More |